MedTrace Logo

Determinants of Compliance With Glaucoma Therapy

NCT00362622 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2012-08-16

No results posted yet for this study

Summary

To determine the association between medical, demographic, socioeconomic, and therapeutic differences on compliance with topical glaucoma therapy using the Travalert device.

Conditions

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Christopher A Girkin, MD · University of Alabama at Birmingham

  • Jason Swanner, MD · University of Alabama at Birmingham

  • Matthew Sapp, MD · University of Alabama at Birmingham

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00362622 on ClinicalTrials.gov